1. 主信息
英文名: | (4aR,6aR,6bS,10R,12aS)-10-[(2S,3R,4S,5R)-3-[(2R,3S,4R,5R,6R)-4-[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[[(2S,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid |
中文名: | Oleanolic acid - 3-O-α-L-rhamnosyl(1→6)β-D- Galactosyl( 1→3)-β-D-glucosyl( 1→3)-α-L-rhamnosyl(1→2)-α-L-arabinoside |
CAS编号: | 1415553-83-1 |
化学分子式: | C59H96O25 |
化学分子量: | 1205.4 g/mol |
SMILES: | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)O)OC4C(C(OC(C4O)OC5C(C(COC5OC6CCC7(C(C6(C)C)CCC8(C7CC=C9C8(CCC1(C9CC(CC1)(C)C)C(=O)O)C)C)C)O)O)C)O)CO)O)O)O)O)O)O |
来源: | 白头翁 |
结构类型: | - |
其它名称或标识: |
- |
2. 供应商与价格
供应商 | 包装规格 | 含量 | 价格(元) | 购买 | 环境要求 | 货期 | 说明 |
科华智慧 | 5mg | HPLC≥98% | 2880 | 点击购买 | 2-8℃ | 现货 | - |
3. 结构
3.1 二维结构
3.2 三维结构
4. 国际命名与标识
4.1 IUPAC Name
(4aR,6aR,6bS,10R,12aS)-10-[(2S,3R,4S,5R)-3-[(2R,3S,4R,5R,6R)-4-[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-[[(2S,3S,4R,5S,6R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
4.2 InChl
InChI=1S/C59H96O25/c1-24-34(62)38(66)41(69)48(77-24)76-23-30-37(65)39(67)42(70)49(80-30)82-45-29(21-60)79-50(43(71)40(45)68)83-46-35(63)25(2)78-51(44(46)72)84-47-36(64)28(61)22-75-52(47)81-33-13-14-56(7)31(55(33,5)6)12-15-58(9)32(56)11-10-26-27-20-54(3,4)16-18-59(27,53(73)74)19-17-57(26,58)8/h10,24-25,27-52,60-72H,11-23H2,1-9H3,(H,73,74)/t24-,25-,27?,28-,29+,30+,31?,32?,33-,34-,35-,36+,37+,38-,39-,40+,41+,42+,43+,44+,45+,46-,47-,48+,49-,50-,51-,52+,56-,57+,58+,59-/m1/s1
4.3 InChlKey
QZULGCOOYJBDJZ-SHELOEASSA-N
4.4 Canonical SMILES
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)O)OC4C(C(OC(C4O)OC5C(C(COC5OC6CCC7(C(C6(C)C)CCC8(C7CC=C9C8(CCC1(C9CC(CC1)(C)C)C(=O)O)C)C)C)O)O)C)O)CO)O)O)O)O)O)O
4.5 lsomeric SMILES
C[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)OC[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)O[C@H]3[C@@H](O[C@@H]([C@H]([C@@H]3O)O)O[C@@H]4[C@@H]([C@H](O[C@@H]([C@H]4O)O[C@@H]5[C@H]([C@@H](CO[C@H]5O[C@@H]6CC[C@@]7(C(C6(C)C)CC[C@]8(C7CC=C9[C@@]8(CC[C@]1(C9CC(CC1)(C)C)C(=O)O)C)C)C)O)O)C)O)CO)O)O)O)O)O)O
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
中文名称 | 英文名称 | 拉丁文名称 |
7. 相关靶点
基因靶点 | 靶点位置 | 参考文献 |
8. 相关疾病
疾病名称 | 疾病类型 | 参考文献 |